Nicole C. Schmitt

Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer

Gulidanna Shayan, Raghvendra M. Srivastava, Jing Li et al. · OncoImmunology · 2016 · 301 citations · Full text

Life Sciences, Immunology, Oncology +17

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz et al. · Clinical Cancer Research · 2019 · 270 citations · Full text

Medicine, Immunology, Oncology +16

PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer

Benjamin Kansy, Fernando Concha‐Benavente, Raghvendra M. Srivastava et al. · Cancer Research · 2017 · 252 citations · Full text

Life Sciences, Immunology, Oncology +17

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma

Linda Tran, Clint Allen, Roy Xiao et al. · Cancer Immunology Research · 2017 · 184 citations · Full text

Medicine, Immunology, Oncology +17

Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer

So Jin Park, Wenda Ye, Roy Xiao et al. · Oral Oncology · 2019 · 182 citations · Full text

Medicine, Cancer Biology, Oncology +7